HESTERBIO

Hester Biosciences Ltd.

NSE: HESTERBIO

BSE: 524669

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

2,347.20-91.7 (-3.76%)

26 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

87.4 / 100

Value Score

43.0 / 100

Price Momentum Score

87.2 / 100

QVM Score

92.1 / 100

Key Metrics

Market Cap

1996.76

P/E (TTM)

14.69

P/B

4.88

P/S (TTM)

6.13

EV/EBITDA

25.27

CAPE (5Y)

40.96

ROE (TTM)

14.32

ROCE (TTM)

11.28

ROA (TTM)

8.36

Avg 3Y ROE

9.26

Earnings 3Y CAGR

65.32

Sales 3Y CAGR

2.41

Sales 5Y CAGR

6.78

Debt/Equity

0.48

Consensus TP

Strong Buy %

Promoter Holding

53.73

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Hester Biosciences Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 14.69 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -51.91%

What is P/E Ratio?

Median: 30.55

Value 14.69

-0.99726.77

Strong price momentum

Price Momentum score of 87.2 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

87.2 / 100

Moderate ROE but improving trend

The company reported moderate ROE of 14.32% for 12-month ended 30 Jun 2026 but ROE improved by 661 bps from 1 year ago

What is ROE (FY)?

High and improving operating margin

The company reported strong operating margin of 20.44% for 12-month ended 30 Jun 2026 and operating margin improved by 467 bps from 1 year ago

What is Operating profit margin?

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 378.44% for 12-month ended 30 Jun 2026 and the growth was 371.24 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.48 as on 30 Jun 2026 and Debt to Equity decreased marginally by 0.1 in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 10 financial years

What is Dividend streak?

Negative

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of 4.09% for 12-month ended 30 Jun 2026 and the growth was 6.5 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 10.59

Value 4.09

-99.6111701.8

Low dividend yield

The company has a low dividend yield of 0.47%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 69.1 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

69.1 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Hester Biosciences Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Hester Biosciences Ltd. Shareholding Pattern

Quarterly breakdown of Hester Biosciences Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73	53.73
Indian Promoter	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28	44.28
Foreign Promoter	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45	9.45
Institutions	0.70	0.78	0.84	0.85	1.42	0.98	0.69	0.82	0.95	0.76	0.65	0.48	0.45	0.45	0.42	0.43	0.43	0.52	0.61	0.59	0.87	0.52	0.53	0.51	0.38	0.31
Mutual Funds / UTI	0.03	0.03	0.17	0.17	0.73	0.40	-	0.02	0.03	0.03	0.03	0.03	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.03	0.13	0.06	0.06	0.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.59	0.62	0.62	0.63	0.60	0.58	0.68	0.80	0.92	0.72	0.62	0.45	0.45	0.45	0.42	0.43	0.43	0.52	0.61	0.59	0.87	0.51	0.53	0.52	0.38	0.31
Other Institutions	0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	45.56	45.48	45.42	45.42	44.84	45.29	45.58	45.45	45.31	45.51	45.61	45.78	45.82	45.82	45.85	45.84	45.84	45.74	45.66	45.67	45.39	45.75	45.74	45.76	45.89	45.95
Bodies Corporate	4.49	4.38	4.14	4.19	3.92	3.34	3.26	3.29	3.20	3.04	3.32	3.04	2.95	2.87	3.17	3.06	3.00	3.31	3.25	3.17	2.70	3.13	2.49	2.35	2.33	2.71
Others (incl. Retail) No. of shareholders	41.07 8,687	41.10 11,209	41.28 11,183	41.23 10,749	40.92 10,324	41.95 15,925	42.32 16,208	42.16 16,104	42.11 14,855	42.47 13,276	42.29 13,527	42.74 13,225	42.87 12,948	42.95 12,814	42.68 13,171	42.78 13,284	42.84 12,686	42.43 11,155	42.41 11,388	42.50 11,324	42.69 11,700	42.62 11,657	43.25 12,106	43.41 12,442	43.56 12,217	43.24 11,816

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Hester Biosciences Ltd. shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

Corporate Actions

History of Hester Biosciences Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 11/share
Record date: 14th Jul 2026Ex-date: 14th Jul 2026
Announced on: 15th May 2026
Dividend₹ 7/share
Record date: 6th Aug 2025Ex-date: 6th Aug 2025
Announced on: 9th May 2025
Dividend₹ 6/share
Record date: 22nd Aug 2024Ex-date: 22nd Aug 2024
Announced on: 10th May 2024
Dividend₹ 8/share
Record date: 13th Sep 2023Ex-date: 13th Sep 2023
Announced on: 17th May 2023
Dividend₹ 10/share
Record date: 12th Aug 2022Ex-date: 11th Aug 2022
Announced on: 20th May 2022

Company Profile

Overview of Hester Biosciences Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Hester Biosciences Limited is an India-based animal healthcare company. The Company is principally engaged in manufacturing poultry vaccines, large animal vaccines, and trading poultry, large animal, and petcare health products. Its segments include Poultry Healthcare, Animal Healthcare, and Others....

Key personnel

Mr. Ashish Dineshbhai Desai

Chief Financial Officer

Mr. Vinod Mali

Compliance Officer, Company Secretary

Dr. Bhupendra Vithaldas GandhiD

Non-Executive Chairman of the Board

Mr. Rajiv Dinesh GandhiD

Chief Executive Officer, Managing Director, Executive Director

Ms. Priya Rajiv GandhiD

Executive Director

Mr. Sanjiv Dinesh GandhiD

Non-Executive Director

Mr. Ashok Bhimrao BhadakalD

Non-Executive Independent Director

Mr. Ameetkumar Hiranyakumar DesaiD

Non-Executive Independent Director

View all

Incorporated on

29 Apr 1987

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

483

IPO date

17 Aug 1994

Free Float

26,56,083

Website

https://www.hester.in/

Phone no.

+917926445107

Address

Pushpak 1st Floor, Motilal Hirabhai Road, Panchvati Circle, AHMEDABAD, 380006, India

Frequently Asked Questions

What is the current share price of Hester Biosciences Ltd.?

The current share price of Hester Biosciences Ltd. is ₹ 2,347.20 as of 26 Aug 2026.

What is the market capitalisation of Hester Biosciences Ltd.?

The market capitalisation of Hester Biosciences Ltd. stands at ₹ 1,996.76 Cr.

What is the PE ratio of Hester Biosciences Ltd.?

The Price-to-Earnings (PE) ratio of Hester Biosciences Ltd. is 14.69 as of the latest trailing twelve months data.

What is the ROE and ROCE of Hester Biosciences Ltd.?

Hester Biosciences Ltd. has a Return on Equity (ROE) of 14.32% and a Return on Capital Employed (ROCE) of 11.28% as per the latest financial reports.

What is the 52-week high and low of Hester Biosciences Ltd.?

The 52-week high of Hester Biosciences Ltd. is - and the 52-week low is -.

What is the dividend yield of Hester Biosciences Ltd.?

The dividend yield of Hester Biosciences Ltd. is 0.47% based on the current market price.

What is the FII and DII holding in Hester Biosciences Ltd.?

Foreign Institutional Investors (FII) hold 0.31%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 43.24% of Hester Biosciences Ltd. shares.

What sector does Hester Biosciences Ltd. belong to?

Hester Biosciences Ltd. operates in the Healthcare sector.

What is the beta of Hester Biosciences Ltd.?

The beta of Hester Biosciences Ltd. is 0.79, indicating its price volatility relative to the broader market. Over the past 1 year, Hester Biosciences Ltd. has delivered an absolute return of 20.50%.

What is the RSI of Hester Biosciences Ltd.?

The 14-day Relative Strength Index (RSI) of Hester Biosciences Ltd. is 45.81, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Hester Biosciences Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Hester Biosciences Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile